In human gastric cancer, there are two probable causes for the low expression or absence of TFF1: 1) potential genetic alterations, including gene mutation, loss of heterozygosity (LOH), and DNA methylation; 2) poorly differentiated cells and glands, which are extremely altered to secrete TFF1 [39,43,46]. This evidence concerns the gene TFF1 and gastric cancer.